Japan, July 1 -- BRISTOL MYERS SQUIBB CO,JANSSEN PHARMACEUTICA NV has got intellectual property rights for 'NOVEL SYNTHETIC METHOD TOWARDS MANUFACTURE OF (6R,10S)-10-{4-[5-CHLORO-2-(4-CHLORO-1H-1,2,3-TRIAZOL-1-YL)PHENYL]-6-OXO-1(6H)-PYRIMIDINYL}-1-(DIFLUOROMETHYL)-6-METHYL-1,4,7,8,9,10-HEXAHYDRO-11,15-(METHENO)PYRAZOLO[4,3-B][1,7] DIAZACYCLOTETRADECIN-5(6H)-ONE.' Other related details are as follows:

Application Number: JP,2025-017468

Category (FI): A61P7/02,C07D401/14,C07D413/06,C07D417/06,C07B61/00,300,C07D401/04,A61K31/506,C07D213/61

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Feb. 5, 2025

Publication Date: June 3, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p01...